Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices

Electromagnetic Interference Clinical Trial

Official title:

Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02252575
• Other study ID #: GER-EP-014
• Status: Completed
• Phase: N/A
• First received: September 26, 2014
• Last updated: February 1, 2018
• Start date: September 2014
• Est. completion date: October 2017

Study information

• Verified date: February 2018
• Source: Deutsches Herzzentrum Muenchen
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates such potential interferences in vivo.

Description:

E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates different types of electric motors with regard to electromagnetic interference with implanted pacemakers or cardioverter-defibrillators.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 107
• Est. completion date: October 2017
• Est. primary completion date: April 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• implanted cardiac implantable electronic device with regular function

Exclusion Criteria:

• implanted cardiac implantable electronic device with irregular function

Related Conditions & MeSH terms

• Electromagnetic Interference

Intervention

Device:
• Electromagnetic field
Exposure to the electromagnetic fields of electric motors

Locations

Country	Name	City	State
Germany	Deutsches Herzzentrum Muenchen	Munich

Sponsors (1)

Lead Sponsor	Collaborator
Deutsches Herzzentrum Muenchen

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Occurrence of electromagnetic interference	Occurrence of electromgantic interference during an exposure time of approximately 5 minutes	acute setting